3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
13
Ovarian Neoplasms
9
Peritoneal Neoplasms
8
Carcinoma, Ovarian Epithelial
6
Fallopian Tube Neoplasms
5
Colorectal Neoplasms
4
Mesothelioma
2
Carcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stage â…¢ Gastric Cancer
1
Stage IV Gastric Cancer With Metastasis
1
Pseudomyxoma Peritonei
1
Pleural Effusion
1
Peritoneal Cancer
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Locally Advanced Colorectal Cancer
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Exploratory Behavior
1
Drug-Related Side Effects and Adverse Reactions
1
Ascites
1
Appendiceal Neoplasms
1
Advanced Gastric Adenocarcinoma
1
Interventions
Gemcitabine
78
Fluorouracil
27
Oxaliplatin
24
130-nm albumin-bound paclitaxel
24
Leucovorin
18
Capecitabine
15
Albumin-Bound Paclitaxel
15
S 1 (combination)
14
Taxes
12
Irinotecan
11
pembrolizumab
9
folfirinox
9
Radiosurgery
9
Radiotherapy
7
Drug Therapy
7
Cisplatin
7
irinotecan sucrosofate
6
Pancreaticoduodenectomy
5
Paclitaxel
5
Injections
5
Docetaxel
5
Blood Specimen Collection
5
apatinib
4
Radiofrequency Ablation
4
Radiation
4
Biopsy
4
tislelizumab
3
rubitecan
3
nimotuzumab
3
camrelizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pancreatic Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT03210298
2019-10-08
PIPACRegis
University of Magdeburg
Unknown
1,000 enrolled